Evaluation of the chemical model of vestibular lesions induced by arsanilate in rats.
Several animal models of vestibular deficits that mimic the human pathology phenotype have previously been developed to correlate the degree of vestibular injury to cognate vestibular deficits in a time-dependent manner. Sodium arsanilate is one of the most commonly used substances for chemical vestibular lesioning, but it is not well described in the literature. In the present study, we used histological and functional approaches to conduct a detailed exploration of the model of vestibular lesions induced by transtympanic injection of sodium arsanilate in rats. The arsanilate-induced damage was restricted to the vestibular sensory organs without affecting the external ear, the oropharynx, or Scarpa's ganglion. This finding strongly supports the absence of diffusion of arsanilate into the external ear or Eustachian tubes, or through the eighth cranial nerve sheath leading to the brainstem. One of the striking observations of the present study is the complete restructuring of the sensory epithelia into a non sensory epithelial monolayer observed at 3months after arsanilate application. This atrophy resembles the monolayer epithelia observed postmortem in the vestibular epithelia of patients with a history of lesioned vestibular deficits such as labyrinthectomy, antibiotic treatment, vestibular neuritis, or Ménière's disease. In cases of Ménière's disease, aminoglycosides, and platinum-based chemotherapy, vestibular hair cells are destroyed, regardless of the physiopathological process, as reproduced with the arsanilate model of vestibular lesion. These observations, together with those presented in this study of arsanilate vestibular toxicity, suggest that this atrophy process relies on a common mechanism of degeneration of the sensory epithelia.
INSERM, ERI27, Caen, F-14000, France.
G
G
Vignaux
C
C
Chabbert
S
S
Gaboyard-Niay
C
C
Travo
M L
ML
Machado
P
P
Denise
F
F
Comoz
M
M
Hitier
G
G
Landemore
B
B
Philoxène
S
S
Besnard
D000818:Animals; D001147:Arsanilic Acid / Q000633:toxicity*; D018069:Hair Cells, Vestibular / Q000187:drug effects / Q000473:pathology; D008297:Male; D009960:Oropharynx / Q000187:drug effects / Q000473:pathology; D051381:Rats; D017207:Rats, Sprague-Dawley; D014722:Vestibule, Labyrinth / Q000187:drug effects* / Q000473:pathology
D001147:Arsanilic Acid